Growth Metrics

Galectin Therapeutics (GALT) Share-based Compensation Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -34.72%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 4.80%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 10.78%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 2.55%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 20.65%
10 Galectin Therapeutics 165.77 Mn 151.67 Mn - 1.19%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.19%
Dec 31, 2025 -34.09%
Sep 30, 2025 -9.91%
Jun 30, 2025 -8.23%
Mar 31, 2025 -18.29%
Dec 31, 2024 19.10%
Sep 30, 2024 -4.27%
Jun 30, 2024 8.30%
Mar 31, 2024 158.42%
Dec 31, 2023 -10.61%
Sep 30, 2023 12.83%
Jun 30, 2023 9.41%
Mar 31, 2023 15.47%
Dec 31, 2022 18.05%
Sep 30, 2022 18.05%
Jun 30, 2022 13.46%
Mar 31, 2022 27.70%
Dec 31, 2021 -47.16%
Sep 30, 2021 737.30%
Jun 30, 2021 -26.16%
Mar 31, 2021 71.00%
Dec 31, 2020 355.49%
Sep 30, 2020 21.05%
Jun 30, 2020 13.57%
Mar 31, 2020 213.17%
Dec 31, 2019 -4.68%
Sep 30, 2019 3.26%
Jun 30, 2019 3.29%
Mar 31, 2019 -30.42%
Dec 31, 2018 296.75%
Sep 30, 2018 -89.20%
Jun 30, 2018 21.73%
Mar 31, 2018 -80.44%
Dec 31, 2017 -80.42%
Sep 30, 2017 -35.99%
Jun 30, 2017 -28.79%
Mar 31, 2017 -17.57%
Dec 31, 2016 -2.33%
Sep 30, 2016 -40.75%
Jun 30, 2016 32.45%
Mar 31, 2016 12.81%
Dec 31, 2015 -51.49%
Sep 30, 2015 -1.07%
Jun 30, 2015 -3.09%
Mar 31, 2015 25.50%
Dec 31, 2014 32.19%
Sep 30, 2014 10.56%
Jun 30, 2014 -17.53%
Mar 31, 2014 -67.24%
Dec 31, 2013 33.06%
Sep 30, 2013 64.79%